Edition:
United Kingdom

People: iRhythm Technologies Inc (IRTC.OQ)

IRTC.OQ on NASDAQ Stock Exchange Global Select Market

82.08USD
20 Aug 2018
Change (% chg)

$-0.04 (-0.05%)
Prev Close
$82.12
Open
$82.06
Day's High
$82.55
Day's Low
$81.93
Volume
2,761
Avg. Vol
97,221
52-wk High
$90.18
52-wk Low
$44.23

Sung, Derrick 

Mr. Derrick Sung, Ph.D. is the Executive Vice President - Strategy and Corporate Development of the Company., since May 2015. From 2008 to 2015, Dr. Sung was the senior equity research analyst covering the medical devices sector for Sanford C. Bernstein & Co., LLC. From 2004 to 2008, he was Director of Marketing and Business Development in Boston Scientific Corp.’s Neuromodulation Division. From 2000 to 2004, Dr. Sung served as a management consultant at The Boston Consulting Group where he advised biopharmaceutical and medical device companies on business strategy, operational effectiveness, and mergers and acquisitions. Dr. Sung began his career in 1994 as a research and development engineer designing heart catheters for Guidant Corporation. Dr. Sung holds a Ph.D. in Bioengineering from U.C. San Diego, an M.B.A. from San Diego State University and a B.S. in Mechanical Engineering from Stanford University.

Basic Compensation

Total Annual Compensation, USD 471,635
Restricted Stock Award, USD 278,475
Long-Term Incentive Plans, USD --
All Other, USD 288,610
Fiscal Year Total, USD 1,038,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Abhijit Talwalkar

192,004

Kevin King

4,715,440

Matthew Garrett

1,605,390

Karim Karti

--

David Vort

1,528,960

Derrick Sung

1,038,720
As Of  31 Dec 2017